Form 4: Fulgent Genetics CFO Paul Kim Reports Stock Withholding

CFO Paul Kim reported the withholding of 1,168 shares of Fulgent Genetics common stock to satisfy tax obligations related to restricted stock unit vesting.

Summary

• Paul Kim, CFO and Treasurer of Fulgent Genetics, Inc., executed a transaction on May 26, 2026.
• 1,168 shares of common stock were withheld by the company at a price of $17.67 per share.
• The transaction was conducted to satisfy tax withholding obligations resulting from the vesting of restricted stock units.
• Following this transaction, Paul Kim maintains beneficial ownership of 364,632 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a mandatory tax withholding rather than a market-driven trade.

Positives

• The transaction is a routine administrative action related to tax obligations rather than a discretionary sale of shares.
• The reporting person retains a significant equity stake of 364,632 shares, aligning interests with shareholders.

Negatives

• None identified; this is a standard tax-related withholding event.

Risks

• None identified; this filing pertains to routine tax withholding.

Future Outlook

Not applicable; this is a retrospective disclosure of a completed transaction.

Industry Context

StockSavvy.ai notes that routine tax withholding filings by executives are standard corporate practice and do not typically signal changes in management sentiment or company outlook.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for equity compensation tax obligations.
• The behavior is consistent with typical executive compensation structures in the biotechnology and diagnostics sector.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors as this is a routine tax-related transaction.

Key Dates

Keywords

Fulgent Genetics, FLGT, Form 4, Insider Transaction, CFO, Tax Withholding